NEUROTROPHIC KERATITIS
Clinical trials for NEUROTROPHIC KERATITIS explained in plain language.
Never miss a new study
Get alerted when new NEUROTROPHIC KERATITIS trials appear
Sign up with your email to follow new studies for NEUROTROPHIC KERATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drops aim to heal corneal damage and restore sensation
Disease control Recruiting nowThis study tests an experimental eye drop called STSP-0902 for people with neurotrophic keratitis, a rare condition where the cornea loses sensation and can develop ulcers. The trial will enroll 48 adults with moderate to severe disease. Participants will receive either the activ…
Matched conditions: NEUROTROPHIC KERATITIS
Phase: PHASE2 • Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Gene therapy eye drops aim to heal corneas in rare nerve disorder
Disease control Recruiting nowThis study tests a new gene therapy called KB801 for people with stage 2 or 3 neurotrophic keratitis, a rare eye disease where the cornea cannot heal itself. The treatment uses a harmless virus to deliver nerve growth factor directly to the eye. About 60 participants will receive…
Matched conditions: NEUROTROPHIC KERATITIS
Phase: PHASE1, PHASE2 • Sponsor: Krystal Biotech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New eye drops aim to heal damaged corneas
Symptom relief Recruiting nowThis Phase 2 trial tests Lacripep eye drops in 54 people with neurotrophic keratitis, a condition where the cornea loses feeling and can get damaged. The study compares the drops to a placebo to see if they safely improve eye surface health, vision, and quality of life over 8 wee…
Matched conditions: NEUROTROPHIC KERATITIS
Phase: PHASE2 • Sponsor: TearSolutions, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC